21 May 2025

Text Messages, Transparency, and the Rule of Law

On 14 May 2025, the General Court of the EU ruled in favour of The New York Times in the much-awaited Pfizergate case, annulling the European Commission's decision to withhold the SMS text messages presumed to have been exchanged between EU Commission President von der Leyen and Pfizer CEO Albert Bourla. While presented as another case concerning document access, potentially illuminating the informal negotiation process behind COVID-19 vaccine contracts and the management and archive of texts and other instant messages, this judgment largely defies this expectation. Continue reading >>
0
18 March 2022

Not Much of a Waiver

Seventeen months after South Africa and India initiated the TRIPS waiver proposal, the negotiating “quad” (South Africa, India, US and the EU) is reported to have reached a compromise at the WTO. The text of the proposal was leaked this week. From a legal perspective, the outcome of the compromise is more muddled and confusing than clarifying, although it claims its aim to be the latter. As it presently stands, the text is not so much a waiver of TRIPS obligations than a modification of existing obligations and conditions of exemptions around patents, as well as an introduction of additional requirements. Continue reading >>
0
31 October 2021

From Charity to Justice in the Pandemic

Waiving intellectual property rights is not a panacea in the current pandemic, but it may remove obstacles and, importantly, would send the right message. Germany should therefore change its position and support a decision in the World Trade Organization (WTO) to that effect. Donations are good and necessary in the short-term, but they must not be mistaken for acts justice in international relations. Continue reading >>
05 October 2021

FRAND Terms for Pandemic-essential Intellectual Property Rights

Our international norms are arguably ill adapted to emergencies such as pandemics. In this contribution I discuss a potential remedy for one related challenge, namely a cooperation amongst competitors for the accelerated development of vaccines. A way to foster cooperation could be the use of fair, reasonable and non-discriminatory (‘FRAND’) terms to the licensing of pandemic-essential intellectual property rights (IPR). Continue reading >>
0
Go to Top